Stereoselective oxidative coupling of methyl trans-ferulate to (±)-trans-dehydrodiferulate dimethyl ester by Trametes versicolor FC: An enantioselective green approach

16 April 2025, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Chemoenzymatic strategies to synthesize complex molecules have been developed by combining biocatalytic and synthetic methods in a multistep approach toward a target molecule. Dihydrobenzofuran neolignans (DBNs), a class of plant-derived natural compounds, display several biological activities. Oxidative coupling of phenylpropanoids is commonly used to obtain DBNs, but yields are low, and stereochemical control is poor. This study reports the novel eco-friendly and stereoselective conversion of methyl trans-ferulate (1) into DBN 2 ((±)-trans-dehydrodiferulate dimethyl ester) promoted by Trametes versicolor FC in 47% yield. Compared to Ag2O-promoted oxidative coupling, this biotransformation approach is enantioselective (66.7% ee of the main enantiomer) and affords DBN 2, as confirmed by chiral-HPLC and NMR data analyses. Our preliminary results highlighted the combination of biotransformation and traditional chemical processes as a promising starting point for obtaining DBNs from the corresponding phenylpropanoids enantioselectively.

Keywords

biotransformation
O-methylcedrusin
chemoenzymatic synthesis
dihydrobenzofuran neolignans
oxidative coupling

Supplementary materials

Title
Description
Actions
Title
Supporting Information - NMR and MS spectra of compound 2
Description
This file contains the 1H and 13C NMR spectrum and the ESI-MS spectrum of compound 2.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.